AnaptysBio, Inc. (ANAB) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
ANAB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ANAB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 99.0% | 20.4% | -5.6% |
| 2024 | -79.5% | -125.9% | -159.1% |
| 2023 | -671.0% | -958.3% | -953.7% |
| 2022 | -763.2% | -1119.4% | -1251.3% |
| 2021 | -55.9% | -89.9% | -91.5% |
Download Data
Export ANAB earnings history in CSV or JSON format
Free sign-in required to download data
AnaptysBio, Inc. (ANAB) Earnings Overview
As of May 8, 2026, AnaptysBio, Inc. (ANAB) reported trailing twelve-month net income of -$13M, reflecting +91.0% year-over-year growth. The company earned $-0.42 per diluted share over the past four quarters, with a net profit margin of -5.6%.
Looking at the long-term picture, ANAB's historical earnings data spans multiple years. The company achieved its highest annual net income of $232,000 in fiscal 2014.
AnaptysBio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCUS (-$369M net income, -142.9% margin), ARQT (-$2M net income, -4.3% margin), DAWN (-$107M net income, -67.8% margin), ANAB has outperformed on profitability metrics. Compare ANAB vs RCUS →
ANAB Earnings vs Peers
Earnings metrics vs comparable public companies
ANAB Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$13M | +90.9% | $48M | $-0.46 | -5.6% | 20.4% |
| 2024 | -$145M | +11.2% | -$115M | $-5.12 | -159.1% | -125.9% |
| 2023 | -$164M | -27.1% | -$164M | $-6.08 | -953.7% | -958.3% |
| 2022 | -$129M | -122.7% | -$115M | $-4.57 | -1251.3% | -1119.4% |
| 2021 | -$58M | -190.0% | -$57M | $-2.11 | -91.5% | -89.9% |
| 2020 | -$20M | +79.5% | -$24M | $-0.73 | -26.6% | -31.8% |
| 2019 | -$97M | -57.9% | -$107M | $-3.60 | -1216.7% | -1342.9% |
| 2018 | -$62M | -105.0% | -$67M | $-2.50 | -1233.1% | -1334.4% |
| 2017 | -$30M | -606.0% | -$29M | $-1.52 | -300.7% | -287.8% |
| 2016 | -$4M | +21.2% | -$3M | $-0.23 | -25.5% | -18.1% |
See ANAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ANAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ANAB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonANAB — Frequently Asked Questions
Quick answers to the most common questions about buying ANAB stock.
Is ANAB growing earnings?
ANAB EPS is $-0.42, with earnings growth accelerating to +91.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-13M.
What are ANAB's profit margins?
AnaptysBio, Inc. net margin is -5.6%, with operating margin at +20.4%. Below-average margins reflect competitive or cost pressures.
How consistent are ANAB's earnings?
ANAB earnings data spans 2013-2025. The accelerating earnings trend is +91.0% YoY. Historical data enables comparison across business cycles.